|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,931.50 GBX | -0.44% |
|
+1.36% | +5.86% |
| 31/07 | Drugmakers, retailers must face 'maximum strength' claim in decongestant false ad litigation in US | RE |
| 31/07 | GSK global supply chain director sells 38,000 shares | AN |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- GSK Stock
- Consensus GSK plc
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
